YOUR DAILY PEPTIDE BRIEFING / SCIENCE / COMMUNITYNew source checks every six hours
Daily Peptide StackNEWS • RESEARCH • COMMUNITY
THE NEWS STACK / SOURCE NOTE

Corrigendum to "The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity" [Pharmacol. Res. 231 (2026) 108365]..

A source-backed record from the peptide news monitor, with the original source linked below.

BEFORE YOU READ

This page links to the original record; it is not an independent analysis or clinical recommendation.

← Back to Research Stack
Research StackPubMed (NCBI)

Corrigendum to "The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity" [Pharmacol. Res. 231 (2026) 108365].

This newly indexed research record examines “Corrigendum to "The role of GLP-1 and GIP receptor agonists in the treatment of diabetes and obesity" [Pharmacol. Res. 231 (2026) 108365].” Use the linked PubMed (NCBI) publication to assess the study design, population, methods, findings and limitations; an indexed record alone should not be read as clinical guidance.

Open original source ↗

Collected Nov 7, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.